By James Juo
After the Supreme Court's recent decision in MedImmune Inc. v. Genentech Inc., 549 U.S. 118 (2007), a "reasonable apprehension of suit" is no longer required for an accused infringer to initiate a declaratory judgment action involving a patent. Although MedImmune articulated a more lenient legal standard for the availability of declaratory relief in patent cases, there must still be a "case or controversy" where...
To continue reading, please subscribe.
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$795 for an entire year!
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$795 for an entire year!
Or access this article for $45
(Purchase provides 7-day access to this article. Printing, posting or downloading is not allowed.)
Already a subscriber?
Sign In